STOCK TITAN

Rogers Corporation - ROG STOCK NEWS

Welcome to our dedicated page for Rogers Corporation news (Ticker: ROG), a resource for investors and traders seeking the latest updates and insights on Rogers Corporation stock.

Rogers Corporation (NYSE: ROG) is a global leader in engineered materials, focusing on enhancing reliability and performance in various industries. With more than 3,000 employees worldwide, Rogers Corporation manufactures its products across 7 countries. The company's primary business segments include Advanced Connectivity Solutions (ACS), Elastomeric Material Solutions (EMS), and Power Electronics Solutions (PES).

The Advanced Connectivity Solutions (ACS) segment produces high-performance circuit materials used in communications infrastructure, automotive, and consumer electronics markets. These materials are essential for enhancing internet connectivity and supporting the rapid growth of communication technologies.

The Elastomeric Material Solutions (EMS) segment offers products designed for cushioning, sealing, and impact protection. These solutions are widely used in the automotive, transportation, and construction industries. EMS products ensure safety and durability, making them indispensable in various applications.

In the Power Electronics Solutions (PES) segment, Rogers Corporation focuses on ceramic substrate materials that are crucial for power module applications. These materials help improve the efficiency and reliability of power electronics, which are vital in clean energy and other technology-driven sectors.

Rogers Corporation's commitment to mission-critical reliability, market-focused innovation, and delivering exceptional value to its customers has positioned it as a trusted partner to many of the world's leading industrial technology providers. The company continually strives to create products that power, protect, and connect our world, driving advancements in clean energy, internet connectivity, and safety.

Rogers Corporation generates significant revenue from key markets in the United States, China, and Germany, while maintaining a global presence that underscores its influence and reach in the industry.

Latest News:

  • --- ---
  • --- ---
  • --- ---
  • --- ---
  • --- ---
  • --- ---
Rhea-AI Summary

Genentech announced that the global Phase III REMDACTA study of Actemra (tocilizumab) plus Veklury (remdesivir) for treating severe COVID-19 pneumonia did not meet its primary endpoint of improved hospital discharge time. No new safety signals were reported for Actemra. The study, conducted with Gilead Sciences, failed to meet key secondary endpoints as well. Previous studies COVACTA did not meet its primary endpoint, while EMPACTA did. Genentech remains committed to evaluating the overall data for potential application of Actemra in COVID-19 treatments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
covid-19
-
Rhea-AI Summary

Genentech has announced the voluntary withdrawal of Tecentriq® (atezolizumab) from the U.S. market for prior-platinum treated metastatic urothelial carcinoma (mUC), following FDA consultation. This decision follows the failure of the IMvigor211 study to meet its primary overall survival endpoint. Genentech emphasizes that other approved indications for Tecentriq remain unaffected. The withdrawal reflects the evolving treatment landscape and aims to uphold the integrity of the FDA's Accelerated Approval Program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
none
-
Rhea-AI Summary

Genentech announced FDA approval for Actemra® (tocilizumab) subcutaneous injection to slow pulmonary function decline in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD). This marks the first biologic therapy approved for this condition, impacting approximately 75,000 patients in the U.S. Key findings from the focuSSced Phase III trial indicated that Actemra reduced lung function decline compared to placebo, although the primary endpoint related to skin fibrosis was not met.

Common side effects included infections, aligning with Actemra's known safety profile.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
none
Rhea-AI Summary

Rogers Corporation (NYSE:ROG) has released its inaugural 2021 ESG Report, detailing its environmental, social, and governance strategies. President and CEO Bruce D. Hoechner emphasized the company's commitment to responsible corporate citizenship and sustainability, tracing roots back to the founder's initiatives on recycling. The report adheres to prominent sustainability frameworks and covers topics such as carbon footprint, diversity, and COVID-19 response. It showcases Rogers' contributions to electric vehicles, renewable energy, and medical applications, aiming for a cleaner and safer future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.63%
Tags
none
-
Rhea-AI Summary

Genentech, part of the Roche Group, announced publication of Evrysdi™ (risdiplam) data from the pivotal FIREFISH study. The study showed that 90% of infants with symptomatic Type 1 spinal muscular atrophy (SMA) survived without permanent ventilation after 12 months of treatment. Additionally, 33% of infants could sit independently for at least 5 seconds. The data highlights the drug's effectiveness in increasing survival of motor neuron (SMN) protein levels. Evrysdi, FDA-approved in August 2020, has promising implications for treating SMA in infants.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.36%
Tags
none
-
Rhea-AI Summary

Rogers Corporation (NYSE:ROG) reported Q4 2020 net sales of $210.7 million, marking a 4% increase from Q3 and a 21% rise year-on-year. Gross margin improved to 38.3%, driven by operational efficiencies despite rising costs. For the full year, net sales totaled $802.6 million, a decline of 11% due to pandemic-related challenges. GAAP earnings per diluted share were $0.81 in Q4, up from $0.37 in Q3, while full-year earnings rose to $2.67. The company anticipates Q1 2021 net sales between $215-$225 million, amidst recovery from a facility fire in South Korea.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.13%
Tags
none
Rhea-AI Summary

Rogers Corporation (NYSE: ROG) announced the retirement of CFO Michael M. Ludwig, who will remain until a successor is appointed. The company praised his leadership in enhancing profitability and cash flow. Rogers specializes in engineered materials across sectors like advanced mobility and connectivity, operating globally with multiple manufacturing facilities. The company highlights risks in forward-looking statements related to management retention and employee costs, indicating potential uncertainties ahead.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.13%
Tags
none
-
Rhea-AI Summary

Genentech has announced positive results from four Phase III studies on its investigational bispecific antibody, faricimab, targeting diabetic macular edema (DME) and wet age-related macular degeneration (nAMD). Faricimab demonstrated non-inferior vision gains compared to aflibercept, with patients able to extend treatment intervals up to four months. Approximately 52.8% of DME patients and 45.7% of nAMD patients achieved four-month dosing in the first year. The studies showed no unexpected safety signals, indicating faricimab may improve treatment adherence and outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
none
-
Rhea-AI Summary

On February 9, 2021, a fire occurred at Rogers Corporation's (NYSE:ROG) UTIS manufacturing facility in Ansan, South Korea. The site was evacuated without injuries, but the facility suffered extensive damage. The fire's cause is under investigation. This site produces eSorba® polyurethane foams, crucial for portable electronics, and will see operational disruptions, though the duration is yet unknown. The UTIS business accounts for less than 4% of Rogers' annual sales and employs about 50 people.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.8%
Tags
none
Rhea-AI Summary

Rogers Corporation (NYSE:ROG) is set to announce its fourth quarter and full year 2020 results on February 18, following market close. This will be accompanied by a conference call at 5:00 pm ET, featuring key executives including President and CEO Bruce Hoechner. Investors can access the live webcast and presentation on Rogers' investor website. The company, with over 180 years of materials science experience, specializes in engineered materials for advanced connectivity, mobility applications, and more, operating globally across multiple countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags

FAQ

What is the current stock price of Rogers Corporation (ROG)?

The current stock price of Rogers Corporation (ROG) is $105.01 as of December 5, 2024.

What is the market cap of Rogers Corporation (ROG)?

The market cap of Rogers Corporation (ROG) is approximately 1.9B.

What is Rogers Corporation known for?

Rogers Corporation is known for its engineered materials that enhance reliability and performance in clean energy, internet connectivity, and safety applications.

How many employees does Rogers Corporation have?

Rogers Corporation employs over 3,000 team members worldwide.

In how many countries does Rogers Corporation manufacture its products?

Rogers Corporation manufactures its products in 7 countries.

What are the main business segments of Rogers Corporation?

The main business segments of Rogers Corporation are Advanced Connectivity Solutions (ACS), Elastomeric Material Solutions (EMS), and Power Electronics Solutions (PES).

Which markets does Rogers Corporation's ACS segment serve?

The ACS segment serves communications infrastructure, automotive, and consumer electronics markets.

What products are offered by the EMS segment of Rogers Corporation?

The EMS segment offers products designed for cushioning, sealing, and impact protection.

What does the PES segment of Rogers Corporation focus on?

The PES segment focuses on ceramic substrate materials for power module applications.

Where does Rogers Corporation generate significant revenue?

Rogers Corporation generates significant revenue from the United States, China, and Germany.

What is the company's approach to innovation?

Rogers Corporation is committed to market-focused innovation, mission-critical reliability, and delivering exceptional value to its customers.

Who are Rogers Corporation's key partners?

Rogers Corporation partners with many of the world's leading industrial technology providers.

Rogers Corporation

NYSE:ROG

ROG Rankings

ROG Stock Data

1.95B
18.58M
0.45%
100.32%
2.96%
Electronic Components
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States of America
CHANDLER